Introduction
============

Intacs^®^ (Addition Technology Inc, Des Plaines, IL, USA) are intrastromal corneal rings consisting of two thin, clear hexagonal polymethyl methacrylate segments. They are placed in surgically created semicircular channels between the stromal lamella at two-thirds the stromal depth during an outpatient procedure. Intrastromal ring segments work by flattening the central corneal curvature, and are adjustable and reversible. Since receiving approval by the US Food and Drug Administration in 1999, they have been used to correct low to moderate myopia[@b1-opth-7-443] and to treat ectasia following laser in situ keratomileusis.[@b2-opth-7-443] Asymmetric implantation of intrastromal corneal ring segments in eyes with keratoconus has been demonstrated to improve both uncorrected and best spectacle-corrected visual acuity, and to reduce irregular astigmatism in corneas with and without scarring.[@b3-opth-7-443]--[@b7-opth-7-443]

Relatively few infectious complications have been reported with the use of the intrastromal corneal segments; channel infections have been infrequently documented,[@b1-opth-7-443],[@b8-opth-7-443]--[@b10-opth-7-443] and only a limited number of infectious keratitis cases have been reported following insertion of Intacs.[@b8-opth-7-443],[@b9-opth-7-443],[@b11-opth-7-443]--[@b16-opth-7-443] Although uncommon, microbial keratitis following intrastromal corneal segments insertion is potentially one of the most serious complications and may be sight-threatening. Appropriate suspicion by the eye care provider along with rapid diagnosis and appropriate management can be critical and result in improved visual recovery.

The purpose of this study was to describe the clinical and pathologic features of *Candida parapsilosis* keratitis, which occurred 8 months following the initially uneventful placement of Intacs inserts for keratoconus. This is the first report in the peer-reviewed literature of *C. parapsilosis* following Intacs insertion and includes molecular confirmation at the species level.

Case report
===========

The patient was a 52-year-old female with a history of keratoconus and no known systemic disease or risk factors for infection. Preoperatively, the patient had uncorrected visual acuity of 20/60 OD and 20/200 OS, and best-corrected visual acuity of 20/30 OD and 20/50 OS, with a refraction of −3.00--3.50 × 170 degrees OD and −5.50--4.50 × 20 degrees OS. Intacs intrastromal corneal ring segments were vertically placed in her left eye for treatment of her keratoconus. Specifically, a 35 ring was inserted superiorly and a 45 ring inferiorly through a 65%--70% depth channel. Good visual rehabilitation was obtained following Intacs insertion (uncorrected visual acuity, OS 20/40; best-corrected visual acuity OS 20/25) and was uneventful at 4 months post insertion ([Figure 1A](#f1-opth-7-443){ref-type="fig"}).

Spontaneous extrusion of the inferior intrastromal corneal ring segment with no indication of infection was noted 5 months after insertion ([Figure 1B](#f1-opth-7-443){ref-type="fig"}), at which time it was removed. The channel was infused with vancomycin solution and a new ring segment was inserted. Eight months post Intacs implantation (3 months post replacement), the location of the lower lateral edge of the intrastromal corneal ring segments showed an epithelial defect and infiltrate on slit-lamp examination ([Figure 1C](#f1-opth-7-443){ref-type="fig"}). The size of the epithelial defect and infiltrate was 1 mm and the infiltrate was at a depth of 40%. The intrastromal corneal ring segments were removed because of suspected infection and the infiltrate was treated for 2 weeks with topical ofloxacin 0.3% every 2 hours and prednisolone acetate 1% once daily. Corneal scrapings cultured on blood agar, chocolate agar, thioglycolate broth, and Sabouraud's agar were negative, as was a Gram stain. The patient was followed weekly and demonstrated flares and exacerbation one month after treatment. The infiltrate progressed into the deep cornea at the level of the intrastromal corneal ring segments at approximately 60% thickness ([Figure 1D](#f1-opth-7-443){ref-type="fig"}). Suspecting mycoplasma and/ or fungus, amphotericin B 0.1% every 2 hours, vancomycin 10 mg/mL every 2 hours, and clarithromycin 12 mg/mL every 2 hours were prescribed for one week without improvement. Therapeutic keratoplasty followed to ensure containment of the infiltrate in the central cornea. Intraoperative amphotericin and vancomycin were dropped open sky in the anterior chamber.

A formal in-fixed keratectomy specimen was histopathologically examined by light microscopy using standard histopathologic techniques, including periodic acid-Schiff staining. The corneal tissue clearly demonstrated insertion channels for the previously removed intrastromal corneal ring segments and a perforating corneal ulcer ([Figure 2](#f2-opth-7-443){ref-type="fig"}). Dense mid-stromal infiltrates and a break in Descemet's membrane were also noted. As seen in the [Figure 2](#f2-opth-7-443){ref-type="fig"} insert, *C. parapsilosis* yeast forms have darker staining central nuclei and produce broad-neck buds.

To confirm the histopathologic findings, the corneal tissue was evaluated using a molecular polymerase chain reaction (PCR)-based diagnostic approach. The forward and reverse panfungal PCR primers encompass a highly conserved region of fungal DNA and are designed to amplify and detect a broad spectrum of fungal DNA without amplifying nonfungal DNA.[@b17-opth-7-443] The current case report corneal specimen was compared with a previously confirmed ocular case of *C. parapsilosis*-induced infectious crystalline keratopathy,[@b18-opth-7-443] with DNA isolated from various species of Candida grown in culture ([Table 1](#t1-opth-7-443){ref-type="table"}), and with plasmid pCA1 DNA that contains a relevant fragment of *Candida albicans* DNA.[@b17-opth-7-443] Formalin-fixed, paraffin-embedded clinical corneal specimens were cut with a microtome at a thickness of 10 μm using precautions necessary for PCR analysis. Twelve to 16 microtome sections were placed into sterile microfuge tubes and the DNA extracted using a protocol previously described[@b19-opth-7-443] and modified.[@b20-opth-7-443] Overnight cultures of *C. parapsilosis*, *C. albicans*, *Candida guilliermondii*, and *Candida* (*Yarrowia*) *lipolytica* were grown as described[@b17-opth-7-443] and processed for DNA extraction using standard genomic DNA methods[@b21-opth-7-443] with modifications previously described.[@b17-opth-7-443] Plasmid pCA1 was grown in *Escherichia coli* DH5-alpha cells and purified.[@b17-opth-7-443] Twenty percent of each DNA sample extracted from the clinical specimens was used for PCR analysis. Approximately 1 × 10^4^ genome equivalents of culture-purified DNA from the control Candida strains and 4 × 10^4^ copies of plasmid pCA1 were used as positive control templates. Deionized distilled water was used as a negative PCR control. The PCR assay conditions had been previously optimized and described.[@b17-opth-7-443],[@b22-opth-7-443],[@b23-opth-7-443] Twenty percent of each PCR assay product was electrophoretically resolved on 1.8% agarose Tris-borate-EDTA gel and visualized using ethidium bromide and ultraviolet excitation. PCR amplicons were compared in size with a 50 bp ladder (Life Technologies, Grand Island, NY, USA).

The current keratoplasty specimen produced a PCR amplicon product of approximately 311 bp, as did the crystalline keratopathy corneal specimen and the DNA from cultured *C. parapsilosis* ([Figure 3](#f3-opth-7-443){ref-type="fig"}). The control DNA from cultured *C. albicans*, *C. guilliermondii*, and *C. lipolytica* produced amplicons of 338 bp, 379 bp, and 242 bp, respectively ([Figure 3](#f3-opth-7-443){ref-type="fig"}) in agreement with the predicted sizes ([Table 1](#t1-opth-7-443){ref-type="table"}). The plasmid pCA1 containing a fragment of *C. albicans* DNA produced the predicted 338 bp PCR product, while the negative control showed no amplification product. The molecular results were in complete concordance with the histopathologic findings and diagnosis. The patient underwent a negative systemic workup, and at one year postoperatively had no signs of recurrence.

Discussion
==========

Intrastromal corneal ring segments are an option in the management of some patients with keratoconus, and their use has been increasing since their efficacy were first reported by Colin et al.[@b5-opth-7-443] According to multiple case studies, microbial keratitis occurs as a complication in approximately 1.4%--6.8% of cases post intrastromal ring segments insertion.[@b15-opth-7-443],[@b24-opth-7-443]--[@b26-opth-7-443] Infectious keratitis following intrastromal corneal ring segments insertion, while uncommon, is potentially one of the most serious complications. Reported microbial species in post-Intacs keratitis include *Staphylococcus aureus*, *Staphylococcus epidermidis*, *Staphylococcus viridans*, *Streptococcus pneumoniae*, *Streptococcus mitis*, *Pseudomonas species*, *Nocardia species*, *Klebsiella species*, *Paecylomices species*, and *Clostridium perfringens*.[@b8-opth-7-443],[@b9-opth-7-443],[@b11-opth-7-443],[@b12-opth-7-443],[@b15-opth-7-443]

Ophthalmologists identified *C. parapsilosis* as a cause for an epidemic of post-cataract endophthalmitis that was linked to intraocular irrigating solutions.[@b27-opth-7-443],[@b28-opth-7-443] This report demonstrates the potential for *C. parapsilosis* to be the etiologic cause of infectious keratitis following insertion of corneal ring segments in the treatment of keratoconus. In addition to its link with the endophthalmitis outbreak and with the current case, *C. parapsilosis* has other ophthalmic associations, such as being the most frequently isolated fungal organism from the normal outer eye in a 1969 study in south Florida[@b29-opth-7-443] and several reports of secondary ophthalmic infections.[@b18-opth-7-443],[@b30-opth-7-443]--[@b38-opth-7-443] It has also been linked with crystalline keratopathy in a corneal graft[@b18-opth-7-443] and suppurative stromal keratitis.[@b32-opth-7-443],[@b39-opth-7-443] A large case series suggests that *C. parapsilosis* accounts for approximately 10% of all causes of yeast keratitis in Southern Florida.[@b32-opth-7-443] Recently, *C. parapsilosis* has been reported as a cause of chronic postoperative endophthalmitis.[@b28-opth-7-443],[@b40-opth-7-443] Furthermore, *C. parapsilosis* has emerged as an important nosocomial pathogen with many systemic clinical manifestations in addition to the ocular manifestation of endophthalmitis.[@b41-opth-7-443] Overall, *C. parapsilosis* has accounted for 3%--27% of cases of fungemia in large hospital-based studies.[@b41-opth-7-443] Candida and other yeasts are more frequently opportunistic than are filamentous fungi.[@b42-opth-7-443] Infections caused by these agents are usually seen in compromised corneas with multiple predisposing alterations in host defense.

Comparison by PCR of the DNA isolated from the current case with various cultured strains of Candida and with previously confirmed *C. parapsilosis*-infected corneal tissue was consistent with the infecting etiologic agent being *C. parapsilosis.* The sensitivity and specificity of any molecular diagnostic approach are important parameters for interpretation of assay results. Establishment of the sensitivity and specificity of the current assay has been previously detailed.[@b17-opth-7-443] The panfungal primers used bracket a region of the fungal genome encoding the highly conserved 5.8s ribosomal RNA (rRNA), internal transcribed sequence-2 (ITS-2), and 28s rRNA. The sequence specificity and assay stringency conditions allow for sensitive amplification of DNA from a wide variety of fungal strains without amplification of human, bovine, murine, bacterial, or viral DNA. While highly conserved, genomic sequence heterogeneity results in variation of the PCR amplicon/product size depending on the specific fungal strain used as a template source. Candida strains produce PCR amplicons ranging in size from 242 bp to 379 bp ([Table 1](#t1-opth-7-443){ref-type="table"}) with *C. parapsilosis* producing a 311 bp PCR product.

This is the first reported case in the peer-reviewed literature of *C. parapsilosis* keratitis following insertion of intrastromal corneal ring segments. The origin of the Candida, whether from the normal ocular flora or introduced from an exogenous source, is not entirely clear and could not be determined from the current study. While the source is unknown, exposure of the stroma by insertion of Intacs may have allowed ingress of the fungus.

Lipid accumulation on the external side of intrastromal ring segments is common and may complicate the clinical picture of an infectious process. During evaluation of any cornea with intrastromal ring segments, it is important to distinguish between the white color of lipid accumulation and that of an infectious infiltrate. Awareness and consideration of an infectious process being potentially responsible for any white banking is important and may play a critical role in correct diagnosis and subsequent treatment.

Patients should be informed of the risk factors and warning signs of infectious keratitis and should be advised to seek medical attention immediately should they develop signs of symptoms of keratitis. Unlike bacterial keratitis, which can be controlled by potent antibiotics, fungal keratitis is difficult to manage because of the lack of effective antifungal agents, low drug bioavailability, ocular toxicity, decreased solubility, and late presentation with large infiltrates. Long-term postoperative observation following intrastromal corneal ring segments insertion is advocated, especially given that the onset of microbial keratitis post implant can vary from days to months.[@b8-opth-7-443],[@b9-opth-7-443],[@b11-opth-7-443]--[@b14-opth-7-443],[@b16-opth-7-443],[@b43-opth-7-443],[@b44-opth-7-443] A high degree of suspicion along with appropriate and complete microbiologic testing, coupled with prompt and appropriate treatment, may result in better visual recovery. This case report adds to the growing and diverse list of organisms and presentations of infectious keratitis following insertion of intrastromal ring segments.
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![Slit-lamp photographs of left eye following intrastromal corneal ring segments (Intacs^®^) insertion. (**A**) Four months after Intacs insertion. (**B**) Spontaneous extrusion of inferior Intacs ring implant (arrow) 5 months following original insertion and prior to ring replacement. (**C**) Initial stromal infiltrates observed 8 months post Intacs insertion (3 months post replacement). (**D**) Stromal infiltrates at 10 months after initial Intacs insertion and prior to therapeutic keratoplasty.](opth-7-443f1){#f1-opth-7-443}

![Histopathologic analysis of keratectomy specimen.\
**Notes:** Micrograph of corneal tissue demonstrating a perforating corneal ulcer (arrow) with Intacs^®^ insertion channels (asterisks) and dense mid-stromal infiltrate (periodic acid-Schiff, original magnification 20×). Insert: micrograph of cultured *Candida parapsilosis* yeast with central nuclei and broad-neck buds (periodic acid- Schiff, original magnification 20×).](opth-7-443f2){#f2-opth-7-443}

![Panfungal polymerase chain reaction analysis.\
**Notes:** Paraffin-embedded corneal specimens and control DNA samples were evaluated using a panfungal polymerase chain reaction assay, electrophoretically resolved on a 1.8% agarose Tris-borate-EDTA gel, and visualized using ethidium bromide and ultraviolet excitation. DNA extracted from the current case report specimen (lane 1), DNA extracted from a confirmed *Candida parapsilosis* infectious crystalline keratopathy clinical specimen (lane 2), 1 × 10^4^ genome equivalents of DNA extracted from cultured *C. parapsilosis* (lane 3), 1 × 10^4^ genome equivalents of DNA extracted from cultured *Candida albicans* (lane 4), 1 × 10^4^ genome equivalents of DNA extracted from cultured *Candida guilliermondii* (lane 5), 1 × 10^4^ genome equivalents of DNA extracted from cultured *Candida lipolytica* (lane 6), 4 × 10^4^ copies of plasmid pCA1 (lane 7), deionized distilled water as a negative control (lane 8), and a 50 bp size marker ladder (lane 9).](opth-7-443f3){#f3-opth-7-443}

###### 

PCR-cultured and plasmid control templates and predicted panfungal PCR product/amplicon sizes

  PCR template                                     Template source[\*](#tfn2-opth-7-443){ref-type="table-fn"}             PCR amplicon size[†](#tfn3-opth-7-443){ref-type="table-fn"}
  ------------------------------------------------ ---------------------------------------------------------------------- -------------------------------------------------------------
  *Candida parapsilosis*                           SRL-F1103 clinical isolate[¶](#tfn4-opth-7-443){ref-type="table-fn"}   311 bp
  *Candida albicans*                               ATCC 28516                                                             338 bp
  *Candida guilliermondii*                         ATCC 6260                                                              379 bp
  *Candida/Yarrowia lipolytica*                    ATCC 18492                                                             242 bp
  pCA1[§](#tfn5-opth-7-443){ref-type="table-fn"}   *C. albicans* EcoRI rDNA fragment in plasmid pUC19                     338 bp

**Notes:**

Source of genomic or plasmid DNA used as PCR control templates;

predicted PCR amplicon size in base pairs according to genome sequence data (GenBank, National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA);

*Candida parapsilosis* ocular isolate from the Sid W Richardson Ocular Microbiology Laboratory fungal culture library, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA;

EcoRI restriction endonuclease enzyme fragment including the ribosomal RNA encoding segment of DNA (rDNA) from the ATCC 32354 strain of *Candida albicans* cloned into the pUC19 plasmid.[@b17-opth-7-443]

**Abbreviations:** ATCC, American Type Culture Collection; PCR, polymerase chain reaction.
